Vanguard Group »

Oncocyte Corporation shares owned by Vanguard Group

Quarter-by-quarter ownership of Oncocyte Corporation (OCX) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Oncocyte Corporation

Tip: Access up to 7 years of quarterly data

All positions including Oncocyte Corporation held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncocyte Corporation by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $721k 245k 2.95
2024-03-31 $726k 248k 2.93
2023-12-31 $620k 248k 2.50
2023-09-30 $749k 240k 3.12